Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.89% is 114% above its 5-year average of -6.48%, near the high end of its 5-year range (-16.04%–2.74%).
0.96% below its 12-month average of 0.90%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 2.74%.
NET PROFIT MARGIN
0.89%
NET PROFIT MARGIN AVG TTM
0.90%
NET PROFIT MARGIN AVG 3Y
-3.05%
NET PROFIT MARGIN AVG 5Y
-6.48%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.96%
CURRENT VS 3Y AVG
+129.19%
CURRENT VS 5Y AVG
+113.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Alignment Healthcare, Inc.
Market Cap
$1.76B
Net Profit Margin
0.89%
TTM Avg
0.90%
3Y Avg
-3.05%
5Y Avg
-6.48%
Market Cap
$1.78B
Net Profit Margin
-672.16%
TTM Avg
-753.31%
3Y Avg
-935.73%
5Y Avg
-797.48%
Market Cap
$1.78B
Net Profit Margin
-636.99%
TTM Avg
-743.17%
3Y Avg
-743.17%
5Y Avg
-743.17%
Market Cap
$1.71B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$1.83B
Net Profit Margin
1.05%
TTM Avg
1.42%
3Y Avg
2.79%
5Y Avg
2.28%
Market Cap
$1.87B
Net Profit Margin
-418.24%
TTM Avg
540.96%
3Y Avg
-464.63%
5Y Avg
-309.76%
Market Cap
$1.65B
Net Profit Margin
10.82%
TTM Avg
2.93%
3Y Avg
-1.36%
5Y Avg
-5.99%
Market Cap
$1.65B
Net Profit Margin
-13.50%
TTM Avg
-22.64%
3Y Avg
-31.77%
5Y Avg
-40.07%
Market Cap
$1.89B
Net Profit Margin
49.06%
TTM Avg
-18.57%
3Y Avg
-80.13%
5Y Avg
-53.74%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alignment Healthcare, Inc. (ALHC) | $1.76B | 0.89% | 0.90% | -3.05% | -6.48% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -672.16% | -753.31% | -935.73% | -797.48% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -636.99% | -743.17% | -743.17% | -743.17% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | -14.99% | -20.12% | -16.95% | -10.04% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.05% | 1.42% | 2.79% | 2.28% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -418.24% | 540.96% | -464.63% | -309.76% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 10.82% | 2.93% | -1.36% | -5.99% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -13.50% | -22.64% | -31.77% | -40.07% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 49.06% | -18.57% | -80.13% | -53.74% |
| Absci Corporation (ABSI)vs › | $1.95B | -7756.37% | -3193.87% | -2536.69% | -2093.05% |
Operating Margin
1.2%
Net Profit Margin
0.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 2.74% |
| 2026-03-31 | 0.92% |
| 2025-12-31 | -1.09% |
| 2025-09-30 | 0.38% |
| 2025-06-30 | 1.54% |
| 2025-03-31 | -0.98% |
| 2024-12-31 | -4.43% |
| 2024-09-30 | -3.81% |
| 2024-06-30 | -3.52% |
| 2024-03-31 | -7.40% |
| 2023-12-31 | -10.14% |
| 2023-09-30 | -7.67% |
| 2023-06-30 | -6.16% |
| 2023-03-31 | -8.49% |
| 2022-12-31 | -15.75% |
| 2022-09-30 | -11.17% |
| 2022-06-30 | -3.16% |
| 2022-03-31 | -11.81% |
| 2021-12-31 | -16.04% |
| 2021-09-30 | -15.61% |
| 2021-06-30 | -14.49% |
| 2021-03-31 | -21.29% |
| 2020-12-31 | -13.23% |
| 2020-09-30 | 4.38% |
| 2020-06-30 | 3.42% |
| 2020-03-31 | -4.48% |
